- Oramed announces publication in diabetes journal
- FDA approves Bayer Diabetes Care's Contour USB blood glucose meter
- UnitedHealth: Cost of diabetes could be $3.35 trillion by 2020
- Walgreens' Pegus to discuss impact of diabetes management on healthcare costs
- Decision Resources: Type 2 diabetes market in China to nearly double by 2014
MANNHEIM, Germany — Roche on Wednesday announced it has received clearance from the Food and Drug Administration for its Accu-Chek Nano SmartView blood-glucose monitoring system. The meter is smaller than a standard credit card, employs a large backlit display and does not require any manual coding or code key for enhanced ease of use, the company stated. It also offers improved functions such as customizable test reminders, pre- and postmeal markers and average glucose calculation.
"The Accu-Chek Nano blood glucose meter will appeal to those who prefer a small, discreet meter with maximum performance," stated Marc Gibeley, head of Roche Diabetes Care North America. "It is easy-to-use and will help people with diabetes regularly check their blood glucose levels before making informed therapy and lifestyle adjustments."
The Accu-Chek Nano meter will be available to customers in the first half of 2012.